Vivtex vs BillionToOne

Side-by-side comparison of AI visibility scores, market position, and capabilities

BillionToOne leads in AI visibility (73 vs 52)
Vivtex logo

Vivtex

ChallengerBioTech

Oral Biologics Drug Delivery

Signed $2.1B Novo Nordisk collaboration (Feb 2026). Platform enables oral delivery of proteins and peptides (historically injection-only). MIT Langer lab spinout.

AI VisibilityBeta
Overall Score
C52
Category Rank
#67 of 198
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
51
Gemini
50

About

Vivtex is an MIT Langer Laboratory spinout that has developed a drug delivery platform enabling oral administration of biologics — proteins, peptides, and other large molecules — that have historically required injection because they are degraded by stomach acid and too large to absorb through the intestinal wall. In February 2026, Vivtex signed a $2.1 billion collaboration agreement with Novo Nordisk for the development of oral formulations of biologic drugs in obesity, diabetes, and metabolic disease.

Full profile
BillionToOne logo

BillionToOne

LeaderLife Sciences & BioTech

Molecular Diagnostics (Prenatal & Oncology)

IPO Nov 2025 (BLLN, Nasdaq); $273M raised; 508K+ tests in 2025; $293–299M revenue guidance FY2025.

AI VisibilityBeta
Overall Score
B73
Category Rank
#14 of 198
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
68
Gemini
75

About

BillionToOne is a leading molecular diagnostics company that has commercialized a proprietary technology platform—Quantitative Counting Templates (QCTs)—enabling detection and quantification of disease-related DNA at single base-pair resolution. This breakthrough in cell-free DNA (cfDNA) analysis underpins its two primary product lines: UNITY Screen for comprehensive prenatal genetic screening (covering carrier status, chromosomal conditions, and fetal risk) and Northstar Select for oncology therapy guidance and liquid biopsy.

Full profile

AI Visibility Head-to-Head

52
Overall Score
73
#67
Category Rank
#14
84
AI Consensus
74
stable
Trend
stable
52
ChatGPT
77
51
Perplexity
68
50
Gemini
75
54
Claude
68
47
Grok
75

Key Details

Category
Oral Biologics Drug Delivery
Molecular Diagnostics (Prenatal & Oncology)
Tier
Challenger
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Vivtex
Oral Biologics Drug Delivery

Integrations

Only Vivtex

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.